IQVIA (IQV)
Technical, fundamental, and sentiment analysis with recent related videos.
IQV rates Neutral overall. The fundamental read is bearish: the company passes 5 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Grey zone (Altman Z = 2.22); revenue is growing about 4.2% per year; net income is growing about 8.2% per year. The technical picture is bullish: price is 31.0% above the 200-day moving average; 3.7% above the 50-day; the 50/200 relationship is in a Golden cross. Sentiment is neutral (composite 55/100), based on 8 news articles from recent coverage.
Revenue 3-year avg +4.2%. Net income 3-year avg +8.2%.
Price vs 20DMA +2.8%. RSI 57.68. Bollinger state: Inside Bands.
Composite score 55/100 from the AI judge, based on 8 news items, 0 television segments, and 0 videos.
Latest Market Read
IQVIA’s three badges tell a mixed story. Fundamental is Bearish: revenue averaged 4.2 percent per year and net income averaged 8.2 percent per year, but recent net‑income weakness pushes the score negative. Technical is Bullish: price sits 2.8 percent above its 20-day moving average, the Relative Strength Index (RSI), a momentum reading, is 57.7, and the stock trades inside the Bollinger Bands. Sentiment is Neutral with a 55/100 composite from eight news items, the tone is mixed but not strong enough to lift the label. The overall rating is Neutral because technical strength is offset by weak fundamentals and only lukewarm sentiment.
Recent news: Coverage is largely a routine Q3 preview and valuation debate ahead of results due Oct 27, with consensus EPS of $3.28 (up 9.3% YoY) and investors focused on clinical development trends and guidance. Sources note a strong three‑year share gain (up 55.3%) and bullish talk about NVIDIA‑powered AI deployment and a US$268 fair value, while others flag heavy debt, tighter data rules, and only modest margin improvement; overall tones are mixed and not decisively directional.
Latest Videos
- No qualified videos yet.